von Tobias Borgers | Nov. 15, 2023 | Markt
In November 2022, OpenAI’s launch of ChatGPT transformed Artificial Intelligence (AI),1 and more specifically, generative AI, from science fiction to an everyday reality. While there is no doubt that generative AI is going to be a disruptive technology across a...
von Tobias Borgers | Nov. 8, 2023 | Markt
Laks Pernenkil, principal and practice leader, US Life Sciences Product & Supply Operations, Deloitte, discusses the impact that digitalization is having on data generation and data integrity in bio/pharma manufacturing.A discussion with Laks Pernenkil, principal...
von Tobias Borgers | Nov. 8, 2023 | Markt
Vedanta Biosciences, a clinical-stage company, has raised $106.5million to support its lead candidate VE303 that aims to stop recurrent Clostridioides difficile infection (CDI). The company has also announced a phase 2 study of VE202 for ulcerative colitis. It says...
von Tobias Borgers | Okt. 25, 2023 | Markt
An influential North America Contract Manufacturing Market report is useful to get answers for several questions that include but are not limited to; who will buy your product? Who are your ideal customer personas? How often will they buy? What do they need?...
von Tobias Borgers | Okt. 19, 2023 | Markt
Novo Nordisk to Acquire Ocedurenone from KBP Biosciences Ocedurenone is currently being evaluated in a phase 3 trial in uncontrolled hypertension with potential in cardiovascular and kidney disease. Novo Nordisk has entered an agreement to acquire ocedurenone for...
von Tobias Borgers | Okt. 19, 2023 | Markt
Ein neues Medikament von Novo Nordisk hat die Aktie von Dialysespezialist Fresenius Medical Care auf Talfahrt geschickt. Fondsmanager Alexander Jenke über die Bedrohungen für andere Pharmariesen. WirtschaftsWoche: Für viele Aktionäre des deutschen Dialysespezialisten...
